ArticleJournal of Crohn's & colitis2023
Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.